Press Releases
ReCode Therapeutics Announces New Funding from the Cystic Fibrosis Foundation, Collaboration with a Leading Gene Editing Company and Leadership Transition
ReCode Therapeutics Achieves a First: Proof of Activity in Primary Ciliary Dyskinesia Patients
ReCode Therapeutics Achieves a First: Proof of Activity in Primary Ciliary Dyskinesia Patients
ReCode Therapeutics Initiates Enrollment of Phase 2 Clinical Trial of RCT2100 in Combination with Ivacaftor for the Treatment of Cystic Fibrosis
RCT-2100 co-administered with ivacaftor will assess the safety and tolerability of inhaled CFTR mRNA therapy over 6 weeks in participants with CF. U.S. sites now enrolling, with U.K. and EU sites expected to begin enrollment in Q1 2026
ReCode Therapeutics Announces Over $29 Million in Additional Financing to Advance Genetic Medicines Pipeline and Provides Corporate Update
Cystic Fibrosis Foundation provides $3 million in new funding to accelerate development of inhaled mRNA therapy for cystic fibrosis. Research collaboration with Praxis Precision Medicines to develop LNP formulations for ASO delivery.
Media Contacts
The Grace Communication Group
Tara Cooper
[email protected]
[email protected]
Media Library
Download assets including ReCode’s logo, high-resolution headshots, and fact sheets.
Presentations
RCT2100 rescues CFTR function in human bronchial epithelial cells and improves mucociliary clearance in CF ferrets
North American Cystic Fibrosis Conference (NACFC) 2024
Aerosolized lipid nanoparticle/mRNA therapy to treat patients with Cystic Fibrosis
2023 Cilia, Mucus and Mucociliary Interactions GRC
Nebulized LNP-formulated DNAI1 mRNA Therapy to Restore Mucociliary Clearance for the Treatment of Primary Ciliary Dyskinesia
2023 Cilia, Mucus and Mucociliary Interactions GRC
Publications & Abstracts
Featured News
Unshackling genetic medicines by enabling delivery beyond the liver
Nature Biopharma Dealmakers
Media Contacts
ReCode Therapeutics
Erica Jefferson
[email protected]
The Grace Group
Tara Cooper
[email protected]
[email protected]
Investor Contact
Stern IR
AnneMarie Fields
[email protected]
[email protected]
Media Library
Download assets including ReCode’s logo, high-resolution headshots, and fact sheets.
